Identification of novel prognostic targets in acute kidney injury using bioinformatics and next generation sequencing data analysis
Basavaraj Vastrad,Chanabasayya Vastrad
DOI: https://doi.org/10.1101/2024.03.17.585400
2024-03-17
Abstract:Acute kidney injury (AKI) is a type of renal disease occurs frequently in hospitalized patients, which may cause abnormal renal function and structure with increase in serum creatinine level with or without reduced urine output. With the incidence of AKI is increasing. However, the molecular mechanisms of AKI have not been elucidated. It is significant to further explore the molecular mechanisms of AKI. We downloaded the GSE139061 next generation sequancing (NGS) dataset from the Gene Expression Omnibus (GEO) database. Limma R bioconductor package was used to screen the differentially expressed genes (DEGs). Then, the enrichment analysis of DEGs in Gene Ontology (GO) function and REACTOME pathways was analyzed by g:Profiler. Next, the protein-protein interaction (PPI) network and modules was constructed and analysed, and the hub genes were identified. Next, the miRNA-hub gene regulatory network and TF-hub gene regulatory network were built. We also validated the identified hub genes via receiver operating characteristic (ROC) curve analysis. Overall, 956 DEGs were identified, including 478 up regulated and 478 down regulated genes. The enrichment functions and pathways of DEGs involve primary metabolic process, small molecule metabolic process, striated muscle contraction and metabolism. Topological analysis of the PPI network and module revealed that hub genes, including PPP1CC, RPS2, MDFI, BMI1, RPL23A, VCAM1, ALB, SNCA, DPP4 and RPL26L1, might be involved in the development of AKI. miRNA-hub gene and TF-hub gene regulatory networks revealed that miRNAs and TFs including hsa-mir-510-3p, hsa-mir-6086 and mir-146a-5p, MAX and PAX2, might be involved in the development of AKI. Various known and newtherapeutic targets were obtained via network analysis. The results of the current investigation might be beneficial for the diagnosis and treatment of AKI.
Bioinformatics
What problem does this paper attempt to address?
The problem that this paper attempts to solve is that the molecular mechanisms of acute kidney injury (AKI) have not been fully elucidated, and there is a lack of effective diagnostic markers and therapeutic targets. Specifically, the study aims to identify new prognostic targets and potential therapeutic genes for AKI through bioinformatics analysis and next - generation sequencing (NGS) data.
### Research Background
- **Introduction to AKI**: Acute kidney injury is a common kidney disease, especially in hospitalized patients, characterized by abnormal renal function and structure, elevated serum creatinine levels, with or without decreased urine output.
- **Increasing Incidence**: With the increasing incidence of AKI, exploring its molecular mechanisms has become particularly important.
- **Known Factors**: Many factors are associated with the occurrence of AKI, such as cardiovascular events, the elderly, mechanical ventilation, nephrotoxic drugs, vasopressin, hypertension, hypercholesterolemia, liver disease, hypoalbuminemia, sepsis, renal ischemia, diabetes, obesity, anemia, and chronic kidney disease.
### Research Objectives
- **Identify New Diagnostic Genes and Therapeutic Targets**: Identify new diagnostic genes and therapeutic targets for AKI through bioinformatics and NGS data analysis.
- **Data Sources**: Use the GSE139061 dataset downloaded from the NCBI Gene Expression Omnibus (GEO) database, which contains glomerular tissue samples from 39 AKI patients and 9 glomerular tissue samples from the normal control group.
### Research Methods
1. **Identification of Differentially Expressed Genes (DEGs)**:
- Use the "Limma" R bioinformatics package to screen for differentially expressed genes (DEGs) between AKI patients and the normal control group.
- Use the Benjamini - Hochberg method to correct the P - value, with the threshold set as P - value < 0.05, |log FC (fold change)| > 2.031 (up - regulated genes) and |log FC (fold change)| < - 1.855 (down - regulated genes).
2. **GO and Pathway Enrichment Analysis**:
- Use g:Profiler for GO (biological process, cellular component, molecular function) and REACTOME pathway enrichment analysis to screen for significantly enriched GO terms and pathways.
3. **Protein - Protein Interaction (PPI) Network Construction and Module Analysis**:
- Construct a PPI network of DEGs based on the HIPIE online database, and use Cytoscape software for adjustment and visualization.
- Apply the Network Analyzer plugin and the PEWCC plugin for topological parameter analysis to screen for hub genes and core modules that may be related to AKI.
4. **Construction of miRNA - Hub Gene Regulatory Network and TF - Hub Gene Regulatory Network**:
- Collect miRNA - hub gene interaction information from the miRNet database to construct a miRNA - hub gene regulatory network.
- Collect transcription factor (TF) - hub gene interaction information from the NetworkAnalyst database to construct a TF - hub gene regulatory network.
5. **Receiver Operating Characteristic Curve (ROC) Analysis**:
- Use the pROC package to draw ROC curves and evaluate the diagnostic performance of hub genes in distinguishing AKI patients from normal individuals.
- Calculate the AUC value, sensitivity, and specificity. Hub genes with an AUC value > 0.60 are considered to have diagnostic value, and hub genes with an AUC value > 0.80 are considered to have high diagnostic value.
### Main Results
- **Identification of DEGs**: A total of 956 DEGs were identified, including 478 up - regulated genes and 478 down - regulated genes.
- **GO and Pathway Enrichment Analysis**: DEGs are mainly involved in biological processes and pathways such as metabolic processes, small - molecule metabolic processes, striated muscle contraction, and metabolism.
- **PPI Network and Module Analysis**: 10 hub genes were screened out, including PPP1CC, RPS2, MDFI, BMI1, RPL23A, VCAM1, ALB, SNCA, DPP4, and RPL26L1.
- **Regulatory Network Construction**: miRNA - hub gene and TF - hub gene regulatory networks were constructed, revealing that multiple miRNAs and TFs may